KR101968475B1 - 코엘렌테라진 유도체 및 이를 이용하는 방법 - Google Patents

코엘렌테라진 유도체 및 이를 이용하는 방법 Download PDF

Info

Publication number
KR101968475B1
KR101968475B1 KR1020137014031A KR20137014031A KR101968475B1 KR 101968475 B1 KR101968475 B1 KR 101968475B1 KR 1020137014031 A KR1020137014031 A KR 1020137014031A KR 20137014031 A KR20137014031 A KR 20137014031A KR 101968475 B1 KR101968475 B1 KR 101968475B1
Authority
KR
South Korea
Prior art keywords
alkyl
coelenterazine
enzyme
compound
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137014031A
Other languages
English (en)
Korean (ko)
Other versions
KR20140003430A (ko
Inventor
디터 에이치. 클라우버트
폰초 마이젠하이머
제임스 언치
원후이 저우
Original Assignee
프로메가 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로메가 코포레이션 filed Critical 프로메가 코포레이션
Publication of KR20140003430A publication Critical patent/KR20140003430A/ko
Application granted granted Critical
Publication of KR101968475B1 publication Critical patent/KR101968475B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020137014031A 2010-11-02 2011-11-02 코엘렌테라진 유도체 및 이를 이용하는 방법 Active KR101968475B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40941310P 2010-11-02 2010-11-02
US61/409,413 2010-11-02
PCT/US2011/058924 WO2012061477A1 (en) 2010-11-02 2011-11-02 Coelenterazine derivatives and methods of using same

Publications (2)

Publication Number Publication Date
KR20140003430A KR20140003430A (ko) 2014-01-09
KR101968475B1 true KR101968475B1 (ko) 2019-04-15

Family

ID=44999921

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137014031A Active KR101968475B1 (ko) 2010-11-02 2011-11-02 코엘렌테라진 유도체 및 이를 이용하는 방법

Country Status (15)

Country Link
US (1) US9487520B2 (enExample)
EP (1) EP2635583B1 (enExample)
JP (1) JP6040157B2 (enExample)
KR (1) KR101968475B1 (enExample)
CN (1) CN103180324A (enExample)
AU (1) AU2011323455B2 (enExample)
BR (1) BR112013010484B1 (enExample)
CA (1) CA2815381C (enExample)
DK (1) DK2635583T3 (enExample)
ES (1) ES2543913T3 (enExample)
IL (1) IL225869A (enExample)
PL (1) PL2635583T3 (enExample)
PT (1) PT2635583E (enExample)
SG (1) SG189494A1 (enExample)
WO (1) WO2012061477A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2815381C (en) 2010-11-02 2019-03-19 Promega Corporation Coelenterazine derivatives and methods of using same
CN103443121B (zh) * 2010-11-02 2016-04-20 普罗梅加公司 新型腔肠素底物及其使用方法
US9273343B2 (en) 2011-09-02 2016-03-01 Promega Corporation Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
EP2900833B1 (en) 2012-09-26 2018-05-30 Promega Corporation Real-time monitoring
CA2906157C (en) 2013-03-15 2022-05-17 G1 Therapeutics, Inc. Highly active anti-neoplastic and anti-proliferative agents
JP6430483B2 (ja) 2013-03-15 2018-11-28 ジー１、セラピューティクス、インコーポレイテッドＧ１ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 化学療法の間の正常細胞の一時的な保護
JP6270127B2 (ja) * 2014-01-17 2018-01-31 国立研究開発法人物質・材料研究機構 ニコチンアデニンジヌクレオチド誘導体を検出する方法
EP3099691B1 (en) * 2014-01-29 2019-11-20 Promega Corporation Pro-substrates for live cell applications
US9790537B2 (en) * 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
EP3313846B1 (en) 2015-06-25 2020-05-06 Promega Corporation Thienopyrrole compounds and uses thereof as inhibitors of oplophorus-derived luciferases
JP7092677B2 (ja) * 2016-02-15 2022-06-28 プロメガ コーポレイション セレンテラジン類似体
JP7212612B2 (ja) 2016-07-28 2023-01-25 プロメガ コーポレイション セレンテラジン類縁体
US10316070B2 (en) 2016-09-09 2019-06-11 Promega Corporation Dual protected pro-coelenterazine substrates
JP7200102B2 (ja) 2016-11-01 2023-01-06 プロメガ コーポレイション エネルギー受容体に係留されたセレンテラジン類縁体
EP3548492B1 (en) * 2016-12-01 2023-07-05 Promega Corporation Cell impermeable coelenterazine analogues
JP7161475B2 (ja) 2016-12-28 2022-10-26 プロメガ コーポレイション 官能化ｎａｎｏｌｕｃ阻害剤
EP3395803A1 (en) * 2017-04-28 2018-10-31 Institut Pasteur Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins
EP3788048A1 (en) 2018-05-01 2021-03-10 Promega Corporation Coelenterazine compounds as nanoluc suicide substrates
EP4140991B1 (en) 2018-06-01 2024-05-15 Promega Corporation Inhibitors of oplophorus luciferase-derived bioluminescent complexes
EP3807419A4 (en) 2018-06-12 2022-09-07 Promega Corporation MULTIPLE LUCIFERASE
KR102114088B1 (ko) * 2018-09-10 2020-06-17 (주)신우에이엔티 웨이퍼 세정용 나노 버블 분사 구조
IL318819A (en) 2018-10-03 2025-04-01 Promega Corp Compounds and methods for stabilizing cholinetyrazine and its derivatives
IL293204B1 (en) 2019-11-27 2026-08-01 Promega Corp Multipartite luciferase peptides and polypeptides
WO2021119149A1 (en) 2019-12-10 2021-06-17 Promega Corporation Compositions and methods for bioluminescent detection using multifunctional probes
EP4337646A4 (en) 2021-05-13 2025-05-21 Promega Corporation BIOLUMINESCENT DETECTION OF DNA SYNTHESIS
WO2026128753A2 (en) 2024-12-12 2026-06-18 Juno Therapeutics, Inc. Methods for assessing cell proliferation of cell compositions

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0134108B1 (en) 1983-08-17 1989-04-05 AlliedSignal Inc. Gas generator and method of generating gas
JP3012274B2 (ja) * 1989-03-22 2000-02-21 日本臓器製薬株式会社 新規ルシフェリン誘導体
US5683888A (en) 1989-07-22 1997-11-04 University Of Wales College Of Medicine Modified bioluminescent proteins and their use
US5368484A (en) 1992-05-22 1994-11-29 Atari Games Corp. Vehicle simulator with realistic operating feedback
ES2301160T3 (es) 1994-01-03 2008-06-16 Promega Corporation Luciferasas mutantes.
US6387675B1 (en) 1994-01-03 2002-05-14 Promega Corporation Mutant luciferases
GB9501170D0 (en) 1994-03-23 1995-03-08 Secr Defence Luciferases
JP3648763B2 (ja) 1994-08-23 2005-05-18 日本油脂株式会社 ウミホタルルシフェリン誘導体および糖加水分解酵素の定量方法
GB9417593D0 (en) 1994-09-01 1994-10-19 Secr Defence Luciferase labelling method
US5670356A (en) 1994-12-12 1997-09-23 Promega Corporation Modified luciferase
IN186115B (enExample) 1995-01-20 2001-06-23 Secr Defence Brit
JPH08294397A (ja) * 1995-04-27 1996-11-12 Nippon Oil & Fats Co Ltd 免疫学的活性物質の測定方法
US6522361B2 (en) 1996-03-08 2003-02-18 Sony Corporation Electronic apparatus having the function of displaying the battery residual quantity and method for displaying the battery residual quantity
JP4026876B2 (ja) * 1996-09-05 2007-12-26 日本食品化工株式会社 発光性シクロデキストリン誘導体及びその製造方法
US5998204A (en) 1997-03-14 1999-12-07 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
GB9707486D0 (en) 1997-04-11 1997-05-28 Secr Defence Enzyme assays
WO1998046739A1 (fr) 1997-04-16 1998-10-22 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Molecules immunomodulatrices et leur procede de production
EP2860252A1 (en) 1997-09-19 2015-04-15 Promega Corporation Thermostable luciferases and methods of production
US6602677B1 (en) 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
JP3694181B2 (ja) 1999-01-05 2005-09-14 キッコーマン株式会社 変異型ルシフェラーゼ、変異型ルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ルシフェラーゼの製造法
RU2251571C2 (ru) 1999-10-26 2005-05-10 Дзе Секретэри Оф Стейт Фор Дефенс РЕКОМБИНАНТНАЯ ТЕРМОСТАБИЛЬНАЯ ЛЮЦИФЕРАЗА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ, ИЗОЛИРОВАННАЯ НУКЛЕИНОВАЯ КИСЛОТА, ЭКСПРЕССИРУЮЩИЙ ВЕКТОР, НАБОР ДЛЯ ИСПОЛЬЗОВАНИЯ В БИОЛЮМИНЕСЦЕНТНОМ АНАЛИЗЕ, АНАЛИТИЧЕСКИЙ ТЕСТ ДЛЯ ОПРЕДЕЛЕНИЯ ПРИСУТСТВИЯ В ОБРАЗЦЕ СоА
GB9925161D0 (en) 1999-10-26 1999-12-22 Secr Defence Novel enzyme
US20010046687A1 (en) 2000-03-31 2001-11-29 Dicesare Joseph L. Method for the enhancement of luminescence intensity from a reaction between adenosine triphosphate (ATP) and a luciferase/luciferin reactant system
EP1156103B1 (en) 2000-04-26 2010-08-11 Chisso Corporation Oplophorus luciferase
JP4613441B2 (ja) 2000-04-26 2011-01-19 チッソ株式会社 新規ルシフェラーゼおよび発光蛋白質
US7118878B1 (en) 2000-06-09 2006-10-10 Promega Corporation Method for increasing luminescence assay sensitivity
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
ATE323174T1 (de) 2000-09-13 2006-04-15 Merck Patent Gmbh Verfahren zur detektion und messung der biomasse
US7268229B2 (en) * 2001-11-02 2007-09-11 Promega Corporation Compounds to co-localize luminophores with luminescent proteins
EP1472238B1 (en) 2002-02-01 2012-07-04 Promega Corporation Bioluminescent protease assay
EP1546162B1 (en) 2002-09-20 2011-06-22 Promega Corporation Luminescence-based methods and probes for measuring cytochrome p450 activity
EP1413584B1 (en) * 2002-10-21 2005-03-02 AXXAM S.r.l. Photoprotein with improved bioluminescence
WO2004059294A2 (en) 2002-12-23 2004-07-15 Promega Corporation Improved luciferase-based assays
DE10303265A1 (de) 2003-01-28 2004-07-29 Roche Diagnostics Gmbh Fluorimetrische Bestimmung von Analyten durch ein intramolekulares Quencher-Fluorophor-Konjugat
KR20050109934A (ko) 2003-01-31 2005-11-22 프로메가 코포레이션 관능기의 단백질로의 공유 테더링
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
JP2006517413A (ja) 2003-02-12 2006-07-27 プロメガ　コーポレイション 光を発光反応から消失させる二重酵素アッセイの方法及びキット
US20040178545A1 (en) 2003-03-14 2004-09-16 Cates Larry E. System for optically analyzing a molten metal bath
WO2005038029A2 (en) 2003-10-10 2005-04-28 Promega Corporation Luciferase biosensor
DE602005016648D1 (de) 2004-01-08 2009-10-29 Univ Zuerich Metallkomplexe mit vitamin b12 als ligand
US7416854B2 (en) 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US7553632B2 (en) 2004-01-22 2009-06-30 Promega Corporation Luminogenic and nonluminogenic multiplex assay
EP2395358B1 (en) 2004-07-30 2017-03-29 Promega Corporation Covalent tethering of functional groups to proteins
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
US20070087400A1 (en) 2004-07-30 2007-04-19 Aldis Darzins Covalent tethering of functional groups to proteins and substrates therefor
US7728118B2 (en) 2004-09-17 2010-06-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
JP4453528B2 (ja) * 2004-10-26 2010-04-21 東京化成工業株式会社 新規化学発光試薬
EP1700865A1 (en) 2005-03-11 2006-09-13 AXXAM S.r.l. Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators
JP4639904B2 (ja) 2005-03-30 2011-02-23 チッソ株式会社 蛍光活性を有するルシフェラーゼの活性増強方法
JP3844082B2 (ja) 2005-04-08 2006-11-08 キッコーマン株式会社 耐熱性ホタルルシフェラーゼ、耐熱性ホタルルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ及び耐熱性ホタルルシフェラーゼの製造法
EP1935986B1 (en) 2005-05-31 2014-04-16 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
EP2778234B1 (en) 2005-05-31 2017-09-27 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
BRPI0616489A2 (pt) * 2005-08-17 2016-11-08 Yeda Res & Dev método para determinar um nível de soro paraoxonase biologicamente ativa, conjunto para determinar a predisposição ou diagnosticar uma desordem associada aos níveis normais ou atividade de uma enzima pon em um sujeito e composição para determinar um nível de soro paraoxonase biologicamente ativa
JP4999341B2 (ja) 2005-09-06 2012-08-15 株式会社バイオエネックス 変異型ホタルルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型ホタルルシフェラーゼの製造方法
US9359635B2 (en) 2006-04-03 2016-06-07 Promega Corporation Permuted and nonpermuted luciferase biosensors
AU2007308745B2 (en) 2006-10-24 2014-01-23 Gene Stream Pty Ltd Luciferase signal enhancing compositions
EP2374875B1 (en) 2006-10-30 2015-09-02 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and funcitional expression
WO2008086035A2 (en) 2007-01-10 2008-07-17 Promega Corporation Split mutant hydrolase fusion reporter and uses thereof
US20080248511A1 (en) 2007-03-26 2008-10-09 Promega Corporation Methods to quench light from optical reactions
CN101849005A (zh) 2007-11-05 2010-09-29 普罗梅加公司 杂合融合报道子及其应用
ATE542903T1 (de) 2008-05-19 2012-02-15 Promega Corp Luciferase-biosensoren für camp
US8183007B2 (en) 2008-07-22 2012-05-22 Promega Corporation ADP detection based methods using adenylate cyclase and bioluminescence
TWI354101B (en) 2008-08-19 2011-12-11 Univ Nat Taipei Technology Fluorimetric indicator for biosensing and manufact
WO2010119721A1 (ja) 2009-04-17 2010-10-21 独立行政法人産業技術総合研究所 超高輝度で安定な人工生物発光酵素
ES2795287T3 (es) 2009-05-01 2020-11-23 Promega Corp Luciferasas de Oplophorus sintéticas con mayor emisión de luz
WO2011038219A1 (en) 2009-09-24 2011-03-31 Promega Corporation Proteases having improved stability, solubility and activity
EP2990479B1 (en) 2010-05-11 2019-03-27 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
US9816127B2 (en) 2010-09-01 2017-11-14 Promega Corporation Oxidized glutathione assay
US9284188B2 (en) 2010-09-03 2016-03-15 The Regents Of The University Of California Cytosolic delivery of materials with endosome-disrupting colloids
CA2815381C (en) 2010-11-02 2019-03-19 Promega Corporation Coelenterazine derivatives and methods of using same
CN103443121B (zh) 2010-11-02 2016-04-20 普罗梅加公司 新型腔肠素底物及其使用方法
US9273343B2 (en) 2011-09-02 2016-03-01 Promega Corporation Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Analytical Sciences, Vol.10, pp. 1013-1015 (1995.)
Chemistry Letters, Vol. 16, pp. 417-418 (1987.)*

Also Published As

Publication number Publication date
AU2011323455A1 (en) 2013-05-30
BR112013010484B1 (pt) 2019-09-03
CA2815381A1 (en) 2012-05-10
ES2543913T3 (es) 2015-08-25
AU2011323455B2 (en) 2017-07-27
CN103180324A (zh) 2013-06-26
JP6040157B2 (ja) 2016-12-07
KR20140003430A (ko) 2014-01-09
IL225869A (en) 2017-09-28
US20120107849A1 (en) 2012-05-03
WO2012061477A1 (en) 2012-05-10
JP2013544242A (ja) 2013-12-12
IL225869A0 (en) 2013-07-31
PL2635583T3 (pl) 2015-11-30
DK2635583T3 (en) 2015-08-03
US9487520B2 (en) 2016-11-08
EP2635583A1 (en) 2013-09-11
CA2815381C (en) 2019-03-19
PT2635583E (pt) 2015-09-11
SG189494A1 (en) 2013-05-31
EP2635583B1 (en) 2015-06-03
BR112013010484A2 (pt) 2016-07-05

Similar Documents

Publication Publication Date Title
KR20140003430A (ko) 코엘렌테라진 유도체 및 이를 이용하는 방법
US9951372B2 (en) Compounds and methods for assaying redox state of metabolically active cells and methods for measuring NAD(P)/NAD(P)H
US8288559B2 (en) Luminogenic compounds and methods to detect cytochrome P450 3A enzymes
JP2017522296A (ja) 活性化可能な水溶性の分子プローブ、その合成のための中間体、および関連する検出方法
US20240059697A1 (en) Coelenterazine analogues
US9868977B2 (en) Red-shifted luciferins and methods of using same
FR2994180A1 (fr) Substrat de glycosidase fluorogene et procede de detection associe
CN105712987A (zh) 人羧酸酯酶1的生物发光探针底物及其制备方法与应用
WO2014057139A2 (en) Precursor molecule for the synthesis of d-luciferin
US20240150363A1 (en) Coelenterazine analogues
Terentyeva et al. Morpholinecarbonyl-Rhodamine 110 based substrates for the determination of protease activity with accurate kinetic parameters
US10995110B2 (en) Trehalose analogues

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 7